Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
March 17, 2016 03:41 pm GMT

Googles GV leads $21M Series B in bioscience firm Cambridge Epigenetix

DNAVC firm GV (n Google Ventures) has made another investment in Europe — its seventh — leading a $21 million Series B round for epigenetic sequencing tech company and Cambridge University spin-out, Cambridge Epigenetix. Read More

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/xVFQhzS76LI/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch